The marijuana sector ended the week on a down note and this came as overall markets pulled off their highs.

Marijuana stocks were heating up at this time last year and many investors are hoping to see a rally similar to the one we saw last year.

While a rally of this nature is possible, it is unlikely.

Selectivity is Key

We continue to preach the theme of selectivity and believe that investors who follow this strategy will outperform their peers.

The Canadian medical marijuana industry is positioned for incredible growth over the coming year and we remain very bullish on this sub-set of marijuana stocks. Today, we want to highlight three Canadian cannabis stocks to watch.

CannTrust: Commences Trading Today

Today, CannTrust Holdings will start trading under the symbol, TRST on the Canadian Securities Exchange.

The company is a leading provider of pharmaceutical grade medical cannabis and operates out of a 50,000-square foot hydroponic facility. CannTrust is currently working on a significant upgrade of its 430,000-square foot greenhouse facility in the Niagara region and the first phase (250,000 square feet of production space) is expected to be operational this year.

CannTrust has seen significant growth in its number of registered patients and has approx. 25,000 active patients. At the end of May, the licensed medical marijuana producer had approximately 15,000 patients.

In the first quarter, CannTrust recorded positive adjusted EBITDA and the company will report second quarter financial results later this month. We are favorable on CannTrust and believe this is an opportunity that investors need to be aware of.

Aurora Cannabis: Continues to Execute

Aurora Cannabis Inc. (ACB.V) (ACBFF) has been making waves in the global marijuana industry and is an industry leader. From Australia to Germany, this Canadian licensed producer continues to execute flawlessly, increase market share, and penetrate new markets.

2017 has been a banner year for Aurora Cannabis and has been highlighted by the company up-listing onto the TSX Exchange, entering Germany’s medical marijuana industry, and making significant investments and partnerships.

Aurora is very focused on increasing production capacity ahead of Canada’s planned rollout of recreational marijuana and this will significantly support growth over the coming years. The company has one of the strongest balance sheets when compared to its peers and is levered to several emerging growth trends throughout the world. We are favorable on the company’s leverage to other legal markets and see it as a company to watch.

Canopy Growth: A Stock to Watch on Weakness

Canopy Growth (WEED.TO) (TWMJF) is by far the largest and most diverse licensed Canadian medical marijuana producer. The company is comprised of several wholly‑owned subsidiaries and has increased its reach by making investments and acquisitions of companies all over the globe.

The company has a very strong balance sheet and has penetrated new international markets. We expect to see Canopy further expand its presence across the globe and see continued growth for years to come.

With more than 58,000 Canadian customers on its online store, Canopy possesses some of the most attractive growth prospects and we expect the company to continue to be a leader for years to come.

Canopy Growth has come off its August highs and the shares have been under pressure following the company’s first quarter earnings report. While the market has responded negatively, we are favorable on this numbers and expect to see strong revenue growth on a quarter-over-quarter basis.